Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000236556 | SCV000293260 | pathogenic | not provided | 2024-04-15 | criteria provided, single submitter | clinical testing | Published functional studies have shown the Y511H variant protein is mislocalized from the nucleus to the cytosol during the G2 phase, forming cytosolic aggegates that lead to early degradation and toxic cell stress (PMID: 25678562); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23365052, 29187684, 25942534, 25678562, 23521649, 32754641, 33433851) |
OMIM | RCV000149568 | SCV000196544 | pathogenic | Hereditary sensory neuropathy-deafness-dementia syndrome | 2013-02-26 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium Ii, |
RCV000149568 | SCV004174780 | uncertain significance | Hereditary sensory neuropathy-deafness-dementia syndrome | 2016-01-06 | no assertion criteria provided | literature only |